Tuarascálacha Rannán na Seirbhísí - St. James's Hospital

FoilseacháinA, Chopra R, Davies A, Towlson K, Williams CDPosttransplant immune-mediated hemolysis.Transfusion. 2002 Feb;42(2):198-204.Sokol RJ, Stamps R, Booker DJ, Scott FM, Laidlaw ST,Vandenberghe EA, Barker HFIdentification of novel regions of amplification anddeletion within mantle cell lymphoma DNA bycomparative genomic hybridization.Br J Haematol. 2002 Feb;116(2):291-8.Allen JE, Hough RE, Goepel JR, Bottomley S, Wilson GA,Alcock HE, Baird M, Lorigan PC, Vandenberghe EA,Hancock BW, Hammond DWGenomic polymorphic profiles in an Irish populationwith meningococcaemia: is it possible to predictseverity and outcome of disease?Genes Immun. 2003 Dec;4(8):533-40.Balding J, Healy CM, Livingstone WJ, White B, Mynett-Johnson L, Cafferkey M, Smith OP.Recombinant FVIIa in the management ofuncontrolled hemorrhageTransfusion. 2003 Dec;43(12):1711-6.O'Connell NM, Perry DJ, Hodgson AJ, O'Shaughnessy DF,Laffan MA, Smith OP.Analysis and results of the recombinant factor VIIaextended-use registry.Blood Coagul Fibrinolysis. 2003 Jun;14 Suppl 1:S35-8.Laffan M, O'Connell NM, Perry DJ, Hodgson AJ,O'Shaughnessy D, Smith OP.Successful use of gemtuzumab ozogamicin in a childwith relapsed CD33-positive acute lymphoblasticleukaemia.Br J Haematol. 2003 Aug;122(4):687-8Cotter M, Rooney S, O'Marcaigh A, Smith OP.The treatment of flexion contracture of the kneeusing the Ilizarov technique in a child withhaemophilia B.Haemophilia. 2003 May;9(3):336-9.Kiely PD, McMahon C, Smith OP, Moore DP.Gemtuzumab ozogamicin in pediatric CD33-positiveacute lymphoblastic leukemia: first clinicalexperiences and relation with cellular sensitivity tosingle agent calicheamicin.Leukemia. 2003 Feb;17(2):468-70.Zwaan CM, Reinhardt D, Jurgens H, Huismans DR,Hahlen K, Smith OP, Biondi A,van Wering ER, Feingold J, Kaspers GJ.Mycoides Fungoides shows concurrent expression ofmultiple genes involved in the TNF signallingpathway; an expression profile studyBlood (2003) 102; 1042-1050Tracey L., Villuendas R., Dotor AM., Spiteri I., OrtiP.,Garcia JF., Rodriguez-Peralto JL., Lawler M., Piris MI.Activation of the c-Jun NH2 terminal kinase (JNK)signalling pathway is essential during PBOX-6-induced apoptosis in chronic myelogenousleukaemia (CML) cellsJ Biol Chem. (2002) 277(21): 18383-183839Mc Gee MM, Campiani G, Ramunno A, Nacci V, LawlerM, Williams CD, Zisterer DM.J Biol Chem.Donor leukaemia following second bone marrowtransplant for severe aplastic anaemiaBone Marrow Transplantation (2002) 29: 453-6Lawler M., Schiara R., McCann SR., Locasciulli A.Targeting of photooxidative damage on singlestrandedDNA representing the bcr-abl chimeric geneusing oligonucleotide-conjugates containing[Ru(phen)3](2+)-like photosensitiser groupsPhotochem Photobiol Sci. (2002) 1(12):1024-103Crean CW, Kavanagh YT, O'Keeffe CM, Lawler M,Stevenson C, Davies RJ, Boyle PH, Kelly JM.Published AbstractsCancer Fatigue in Ireland: All Ireland FatigueCoalition (AIFC) professional and interim patientsurveysProc ASCO 2003; 22: 764Eatock MM, Dillon E, Corcoran B, O’Reilly M, Moriarty M,Furlong E, Daly P, Berger A, Keane M, Johnston P.A possible role for tumour necrosis factor-alpha inthe carcinogenesis of malignant mesothelioma.Proc Am Assoc Cancer Res 2003; 44: abstract 4154(Poster)WA Swain, CE Houghton, E Coyle, SP Faux, T Gant, KJO'ByrneVariant -catenin expression is associated with a poorprognosis in non-small cell lung cancer (NSCLC).Proc Am Soc Clin Oncol 2003: 22: abstract 2577(Poster)Swinson, J Lolljee, G Edwards, J Jones, G Cox, D8383